Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
18.76
-0.01 (-0.05%)
At close: Oct 28, 2026, 4:00 PM EDT
18.71
-0.05 (-0.27%)
Pre-market: Oct 29, 2026, 7:27 AM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $2.13 billion as of October 28, 2026. It is the 6,320th most valuable company in the world and the 1,732nd biggest in the United States. Its market cap has increased by 47.46% in one year.
Market Cap
2.13B
Enterprise Value
1.62B
1-Year Change
47.46%
Global Rank
Country Rank
#1,732 United States
Category
ChartMarket Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.13B, an increase of 1,812.83%. That is a compound annual growth rate of 62.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 2.13B | -10.09% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.24B |
| Xencor | 2.23B |
| Vericel | 2.22B |
| Harmony Biosciences Holdings | 2.21B |
| Precigen | 2.20B |
| Vera Therapeutics | 2.16B |
| Maravai LifeSciences Holdings | 2.14B |
| Septerna | 2.06B |